This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Stocks Promising Abundant Gains This Thanksgiving Week
by Sweta Killa
Consumer spending is likely to reach $125 billion, up 10% year over year, this Thanksgiving weekend despite higher inflation and higher interest rates.
Dillard's and Match Group have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Dillard's and Match Group are part of Zacks Bull and Bear of the Day article.
Bull of the Day: Dillard's (DDS)
by Kevin Cook
Another triple-digit EPS beat sees analysts raise estimates 10% for next year, keeping valuation attractive
If You Invested $1000 in Dillard's a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Dillard's (DDS) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Dillard's (DDS) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Children's Place (PLCE) Q3 Earnings Lag Estimates, View Cut
by Zacks Equity Research
The Children's Place's (PLCE) third-quarter fiscal 2022 results reflect decline in net sales and earnings amid a record inflationary environment. Management lowers fiscal 2022 view.
Kohl's (KSS) Q3 Earnings Top Estimates, Stock Down on Low Sales
by Zacks Equity Research
Kohl's (KSS) third-quarter fiscal 2022 results reflect lower sales and earnings due to a tough macroeconomic landscape. Management withdraws fiscal 2022 guidance.
The TJX Companies' (TJX) Q3 Earnings Top Estimates, Sales Down
by Zacks Equity Research
The TJX Companies (TJX) Q3 results reflect lower sales with a decline in almost all regions. The company's earnings increase year over year.
Why Dillard's (DDS) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Dillard's (DDS) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Dillard's (DDS) and Kroger (KR) have performed compared to their sector so far this year.
Sally Beauty's (SBH) Q4 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Sally Beauty's (SBH) fourth-quarter fiscal 2022 sales and earnings decline year over year on weakness across the Sally Beauty Supply segment.
Dillard's (DDS) Surpasses Earnings & Revenue Estimates in Q3
by Zacks Equity Research
Dillard's (DDS) Q3 results gain from continued strong consumer demand. However, inflationary pressure is concerning.
Dillard's (DDS) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Dillard's (DDS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Dillard's (DDS) delivered earnings and revenue surprises of 125.05% and 3.61%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNX
Dillard's (DDS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Dillard's (DDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNY
What to Expect from Dillard's (DDS) Q3 Earnings
by Shaun Pruitt
Dillard's (DDS) third quarter earnings on November 9 will be significant and insightful into the effects an economic downturn is having on the economy. Earnings estimate revisions trending higher is a good sign that the company may beat earnings expectations again.
Factors Likely to Influence Dillard's (DDS) in Q3 Earnings
by Zacks Equity Research
Dillard's (DDS) Q3 results are expected to reflect gains from strong demand trends and efficient inventory management amid rising SG&A expenses and supply-chain costs.
Is First Trust Mid Cap Core AlphaDEX ETF (FNX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNX
Dillard's (DDS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed the most recent trading day at $328.79, moving +1.13% from the previous trading session.
Are Retail-Wholesale Stocks Lagging Dillard's (DDS) This Year?
by Zacks Equity Research
Here is how Dillard's (DDS) and Kroger (KR) have performed compared to their sector so far this year.
Here's How Much a $1000 Investment in Dillard's Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Dillard's (DDS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $322.21 in the latest trading session, marking a +0.72% move from the prior day.
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY